NCT03397823

Brief Summary

Overcoming limitations of previous studies, the following research project will assess the most significant acute and long-term complications of RT that affect HNC patients: oral mucositis, dry mouth feeling, taste alteration and carious lesion incidence, all of which negatively affect cancer treatment outcomes and the quality of life of cancer survivors. This project was developed with an aim to study any possible correlations / links between the oral sequelae of RT and the negative clinical outcomes listed, in order to help the development of clinical management protocols for HNC patients to mitigate the effect on care and patient comfort and its delivery in healthcare systems. The project comprises of a longitudinal cohort study of HNC patients correlating biodata of biochemical salivary parameters, clinical outcomes and oral health status over a period up to 12 months post-RT, focusing on baseline pre-IMRT (T0), 6 months post-IMRT (T1) and up to 12 months post-IMRT treatments (T2). The ultimate goal is to identify possible predictive markers in the saliva at T0 to assist with evaluation of oral mucositis severity in individual HNC patients prior to start of treatment so that treatment can be adapted for such high-risk patients individually, to either prevent or minimise the severity of this consequence of RT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2017

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2017

Completed
29 days until next milestone

First Posted

Study publicly available on registry

January 12, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2019

Completed
Last Updated

September 13, 2021

Status Verified

December 1, 2018

Enrollment Period

2.7 years

First QC Date

December 14, 2017

Last Update Submit

September 6, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Effects of IMRT on saliva composition and potential associations with oral side effects

    integrated longitudinal study of HNC patients correlating biodata of biochemical parameters, clinical parameters and oral health status

    october 2019

Secondary Outcomes (3)

  • IMRT effects on oral cavity

    2019

  • IMRT effects on biochemical composition of saliva

    2019

  • Association between selected salivary proteins and oral mucositis outcomes after IMRT

    2019

Study Arms (3)

head and neck cancer pre RT

head and neck cancer patients before and after RT

head and neck cancer treated

head and neck cancer patients treated with radiotherapy

control group

age gender matched subjects

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Head and neck cancer patients treated with radiotherapy

You may qualify if:

  • Head and Neck Cancer Patients Male or female Over the age of 18. Received radiation treatment for Head and Neck cancer

You may not qualify if:

  • Subjects younger than 18. Patients unable to give consent. Patients with non-controlled systemic disease Distant metastases Patients who have been administered antibiotics in the previous 3 months Patients with Sjogren syndrome. Patients with Rheumatoid arthritis Neurological disorders (Parkinson's disease) Dehydration Sialoadenitis Sialolithiasis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

kings college london, Guy's Hospital

London, SE1 9RT, United Kingdom

Location

MeSH Terms

Conditions

Head and Neck NeoplasmsRadiation Injuries

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsWounds and Injuries

Study Officials

  • avijit banerjee, professor

    King's College London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2017

First Posted

January 12, 2018

Study Start

February 15, 2017

Primary Completion

October 30, 2019

Study Completion

October 30, 2019

Last Updated

September 13, 2021

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share

the participants are allocated with a number its not possible to identify them

Locations